Current Neuro-Oncology

Volume 23 Number 9
15 May 2021

Home > Publications > Current Neuro-Oncology > Volume 23, Year 2021 > Number 9, 15 May

Huang WY, Wen LH, Wu G, Pang PP, Ogbuji R, Zhang CC, Chen F, Zhao JN.
Radiological model based on the standard magnetic resonance sequences for detecting methylguanine methyltransferase methylation in glioma using texture analysis.
Cancer Sci. 2021 May 1
. doi: 10.1111/cas.14918. PMID: 33932065. Observational study. ˍ


Kheiri G, Habibi Z, Nejat F.
Spontaneous regression of congenital brain tumors: a report of two cases.
Childs Nerv Syst. 2021 May 1
. doi: 10.1007/s00381-021-05172-1. PMID: 33934203. Case report. ˍ


Weller J, Katzendobler S, Karschnia P, Lietke S, Egensperger R, Thon N, Weller M, Suchorska B, Tonn JC.
PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression.
J Neurooncol. 2021 May 1
. doi: 10.1007/s11060-021-03765-z. PMID: 33932195. Observational study. ˍ

Likar R, Koestenberger M, Stutschnig M, Nahler G.
Cannabidiol Μay Prolong Survival in Patients With Glioblastoma Multiforme.
Cancer Diagn Progn. 2021 May 3, 2021;1(2):77-82
. doi: 10.21873/cdp.10011. PMID: 35403130. Observational study. ˍ

Ronsley R, Hounjet CD, Cheng S, Rassekh SR, Duncan WJ, Dunham C, Gardiner J, Ghag A, Ludemann JP, Wensley D, Rehmus W, Sargent MA, Hukin J.
Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.
Cancer Med. 2021 May 3, 2021;10(11):3556-3564
. doi: 10.1002/cam4.3910. PMID: 33939292. Case report. ˍ

Lin NU, Pegram M, Sahebjam S, Ibrahim N, Fung A, Cheng A, Nicholas A, Kirschbrown W, Kumthekar P.
Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study.
J Clin Oncol. 2021 May 4,
2021;39(24):2667-2675. doi: 10.1200/JCO.20.02822. PMID: 33945296. Interventional study. ˍ

Cao L, Rong P, Zhu G, Xu A, Chen S.
Clinical Characteristics and Overall Survival Prognostic Nomogram for Oligodendroglioma: A Surveillance, Epidemiology, and End Results Population-Based Analysis.
World Neurosurg. 2021 May 5
, 2021;151:e810-e820. doi: 10.1016/j.wneu.2021.04.122. PMID: 33964496. Observational study. ˍ

Duc NM.
The impact of magnetic resonance imaging spectroscopy parameters on differentiating between paediatric medulloblastoma and ependymoma.
Contemp Oncol (Pozn). 2021 May 6, 2021;25(2):95-99
. doi: 10.5114/wo.2021.105939. PMID: 34667435. Interventional study. ˍ

Kudulaiti N, Zhou Z, Luo C, Zhang J, Zhu F, Wu J.
A nomogram for individualized prediction of overall survival in patients with newly diagnosed glioblastoma: a real-world retrospective cohort study.
BMC Surg. 2021 May 6;21(1):238
. doi: 10.1186/s12893-021-01233-z. PMID: 33957923. Observational study. ˍ


Almengló C, Caamaño P, Fraga M, Devesa J, Costoya JA, Arce VM.
From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro.
J Cell Physiol. 2021 May 7
. doi: 10.1002/jcp.30409. PMID: 33959982. Laboratory investigation. ˍ


Durgin JS, Henderson F Jr, Nasrallah MP, Mohan S, Wang S, Lacey SF, Melenhorst JJ, Desai AS, Lee JYK, Maus MV, June CH, Brem S, O'Connor RS, Binder Z, O'Rourke DM.
Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma.
Front Oncol. 2021 May 7, 2021;11:669071
. doi: 10.3389/fonc.2021.669071. PMID: 34026647. Case report. ˍ

El-Khouly FE, Veldhuijzen van Zanten SEM, Jansen MHA, Bakker DP, Sanchez Aliaga E, Hendrikse NH, Vandertop WP, van Vuurden DG, Kaspers GJL.
A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma.
J Neurooncol. 2021 May 7
. doi: 10.1007/s11060-021-03763-1. PMID: 33963476. Interventional study. ˍ

Jiang H, Yu K, Cui Y, Ren X, Li M, Yang C, Zhao X, Zhu Q, Lin S.
Combination of Immunotherapy and Radiotherapy for Recurrent Malignant Gliomas: Results From a Prospective Study.
Front Immunol. 2021 May 7, 2021;12:632547
. doi: 10.3389/fimmu.2021.632547. PMID: 34025640. Interventional study. ˍ

Vega-Moreno DA, Santellán-Herández JO, Velázquez-Domínguez HE, Martínez-Nava AO, Vicuña-González RM, Mendoza-Trillo PR, Reyes-Rodríguez VA, Ibarra de la-Torre A, González-González IE, Ochoa-Cacique D, Sánchez-Mata R, Molina-Martinez RP, García-González U.
Histopathological correlation (WHO Classification) of meningiomas and their anatomical localization. Multicenter epidemiological study in Mexico.
World Neurosurg. 2021 May 8, 2021;151:e888-e898. doi: 10.1016/j.wneu.2021.05.003. PMID: 33974982. Observational study. ˍ

Bas A, Valiyev E, Ozkan ND, Tombul I, Yonat S, Sayan M, Kurul IC.
A Rare Entity: Primary Pulmonary Meningioma.
Turk Patoloji Derg. 2021 May 10
. doi: 10.5146/tjpath.2021.01535. PMID: 34514565. Letter to the editor. ˍ

Compter I, Verduin M, Shi Z, Woodruff HC, Smeenk RJ, Rozema T, Leijenaar RTH, Monshouwer R, Eekers DBP, Hoeben A, Postma AA, Dekker A, De Ruysscher D, Lambin P, Wee L.
Deciphering the glioblastoma phenotype by computed tomography radiomics.
Radiother Oncol. 2021 May 10, 2021;160:132-139
. doi: 10.1016/j.radonc.2021.05.002. PMID: 33984349. Observational study. ˍ


Salmaggi A, Corno C, Maschio M, Donzelli S, D'Urso A, Perego P, Ciusani E.
Synergistic Effect of Perampanel and Temozolomide in Human Glioma Cell Lines.
J Pers Med. 2021 May 10, 2021;11(5):390
. doi: 10.3390/jpm11050390. PMID: 34068749. Laboratory investigation. ˍ

Zamora PL, Miller SR, Kovoor JJ.
Single institution experience in re-irradiation of biopsy-proven diffuse intrinsic pontine gliomas.
Childs Nerv Syst. 2021 May 10
. doi: 10.1007/s00381-021-05195-8. PMID: 33973056. Observational study. ˍ

Shim KY, Chung SW, Jeong JH, Hwang I, Park CK, Kim TM, Park SH, Won JK, Lee JH, Lee ST, Yoo RE, Kang KM, Yun TJ, Kim JH, Sohn CH, Choi KS, Choi SH.
Radiomics-based neural network predicts recurrence patterns in glioblastoma using dynamic susceptibility contrast-enhanced MRI.
Sci Rep. 2021 May 11, 2021;11(1):9974
. doi: 10.1038/s41598-021-89218-z. PMID: 33976264. Observational study. ˍ

Ferroli P, Vetrano IG, Schiavolin S, Acerbi F, Zattra CM, Schiariti M, Leonardi M, Broggi M.
Brain Tumor Resection in Elderly Patients: Potential Factors of Postoperative Worsening in a Predictive Outcome Model.
Cancers (Basel). 2021 May 12, 2021;13(10):2320
. doi: 10.3390/cancers13102320. PMID: 34065990. Observational study. ˍ

Huang R, Wang T, Liao Z, Wang Z, Ye M, Zhou D, Xie H, Bai Y, Qiu Y, Liu Y.
A Observational study of the risk factors affecting recurrence time in patients with recurrent glioblastoma.
Ann Palliat Med. 2021 May 12, 2021;10(5):5391-5399
. doi: 10.21037/apm-21-823. PMID: 34044551. Observational study. ˍ

Sim HW, McDonald KL, Lwin Z, Barnes EH, Rosenthal M, Foote MC, Koh ES, Back M, Wheeler H, Sulman EP, Buckland ME, Fisher L, Leonard R, Hall M, Ashley DM, Yip S, Simes J, Khasraw M.
A randomized phase II trial of veliparib, radiotherapy and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study.
Neuro Oncol. 2021 May 13,
2021;23(10):1736–1749. doi: 10.1093/neuonc/noab111. PMID: 33984151. Interventional study. ˍ


van den Bent MJ, Tesileanu CMS, Wick W, Sanson M, Brandes AA, Clement PM, Erridge S, Vogelbaum MA, Nowak AK, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Rogers L, Taal W, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Caparrotti F, Lesimple T, Clenton S, Gijtenbeek A, Lim E, Herrlinger U, Hau P, Dhermain F, de Heer I, Aldape K, Jenkins RB, Dubbink HJ, Kros JM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, French P, Baumert BG.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol. 2021 May 14, 2021;22(6):813-823
. doi: 10.1016/S1470-2045(21)00090-5. PMID: 34000245. Observational study. ˍ